Skip to main content
. 2010 Jan 15;24(2):171–182. doi: 10.1101/gad.552910

Figure 1.

Figure 1.

RARα predicts the outcome in breast cancer patients. RARα expression levels in 263 breast cancer patients, all of whom received endocrine therapy, were used to predict positive clinical outcome (recurrence-free survival).